Recombinant UPF0102 protein Rv2898c/MT2966 (Rv2898c, MT2966)

What is the structural classification of UPF0102 protein Rv2898c/MT2966?

UPF0102 protein Rv2898c/MT2966 belongs to the UPF0102 protein family, which contains proteins of unknown function. The structural analysis reveals similarities to other members of this family, characterized by conserved domains that suggest potential roles in cellular processes. The protein appears to share functional homology with the yraN protein, which has been more extensively characterized in other bacterial species. The three-dimensional structure includes characteristic alpha-helical regions that may be involved in protein-protein interactions or substrate binding essential for its biological function, though specific binding partners remain to be definitively identified.

What expression systems are most effective for recombinant UPF0102 protein Rv2898c/MT2966 production?

Multiple expression systems have been validated for UPF0102 protein production, with varying advantages depending on research needs. E. coli and yeast expression systems typically provide the highest yields and shorter turnaround times, making them optimal for structural studies and preliminary functional assays . For applications requiring post-translational modifications, insect cells with baculovirus or mammalian expression systems are preferable as they can provide many of the post-translational modifications necessary for correct protein folding and retention of biological activity . The choice between these systems should be guided by experimental requirements, with consideration of factors such as protein solubility, yield requirements, and the necessity of native conformational states.

How does UPF0102 protein Rv2898c/MT2966 relate to Mycobacterium tuberculosis pathogenesis?

While direct evidence linking Rv2898c/MT2966 to pathogenesis mechanisms remains limited, comparative analysis with other mycobacterial proteins suggests potential functional relationships. Research on related M. tuberculosis proteins indicates potential roles in drug resistance pathways, similar to the efflux pump genes (Rv3065, Rv2942, Rv1258c, Rv1410c, and Rv2459) that contribute to multidrug resistance phenotypes . These efflux pumps can actively export antibiotics from bacterial cells, reducing intracellular drug concentrations and contributing to treatment failure. By extension, Rv2898c may participate in similar cellular defense mechanisms, though direct experimental evidence would be needed to confirm this hypothesis.

What are the optimal conditions for high-yield expression of recombinant UPF0102 protein Rv2898c/MT2966?

Optimal expression conditions for recombinant UPF0102 protein Rv2898c/MT2966 require careful optimization of multiple parameters. In E. coli systems, BL21(DE3) or Rosetta strains typically yield better results than standard DH5α strains. Expression should be performed at lower temperatures (16-25°C) after induction to facilitate proper protein folding, particularly when using IPTG concentrations between 0.1-0.5 mM. For yeast expression systems such as Pichia pastoris, methanol induction protocols with gradual methanol addition over 72-96 hours provide superior yields compared to single-dose methods . When using insect cell expression systems, infection at an MOI (multiplicity of infection) of 2-5 and harvesting 48-72 hours post-infection typically yields the best balance between protein quantity and quality.

What purification strategies maximize both purity and activity of UPF0102 protein Rv2898c/MT2966?

Multi-step purification approaches yield the highest purity while preserving biological activity. Initial capture using affinity chromatography (Ni-NTA for His-tagged constructs) should be followed by ion exchange chromatography to remove co-purifying contaminants. Size exclusion chromatography serves as a final polishing step to ensure homogeneity. Buffer optimization is critical, with the addition of 5-10% glycerol and 1-2 mM reducing agents (DTT or β-mercaptoethanol) significantly improving protein stability during purification. To preserve activity, avoid freeze-thaw cycles by aliquoting the purified protein and storing at -80°C. Typical purification yields approximately 5-10 mg of pure protein per liter of bacterial culture, while yields from eukaryotic expression systems are generally lower but may exhibit superior functional activity due to proper folding and post-translational modifications .

How can researchers assess the quality and functional integrity of purified UPF0102 protein Rv2898c/MT2966?

Quality assessment requires a combination of analytical techniques. Purity should be verified through SDS-PAGE (>95% homogeneity) and Western blotting with specific antibodies. Structural integrity can be evaluated using circular dichroism spectroscopy to confirm proper secondary structure formation. Thermal shift assays provide information on protein stability and can be used to optimize buffer conditions. For functional integrity, in vitro assays examining potential enzymatic activities or binding interactions should be developed based on predicted functions. Mass spectrometry should be employed to verify protein identity and assess post-translational modifications. Additionally, dynamic light scattering helps ensure the protein exists in a monodisperse state rather than forming aggregates, which is essential for downstream structural and functional studies.

How can researchers design experiments to investigate the role of UPF0102 protein Rv2898c/MT2966 in drug resistance pathways?

Investigation of Rv2898c's potential role in drug resistance requires a multi-faceted experimental approach. Gene expression studies using quantitative real-time PCR (RT-qPCR) should compare expression levels between drug-sensitive and resistant strains, similar to methodologies used for other Rv proteins . The experimental design should include reference genes for normalization (such as polA) and establish appropriate cut-off values for overexpression (>4-fold is commonly used) .

The following experimental design framework is recommended:

• Generate recombinant Mycobacterium tuberculosis strains with:

  • Rv2898c overexpression

  • Rv2898c deletion/knockdown

  • Wild-type controls

• Determine minimum inhibitory concentrations (MICs) for various antibiotics in each strain.

• Include efflux pump inhibitors in parallel experiments to assess contribution to resistance.

• Employ time-series experimental designs to track the development of resistance over multiple generations .

This approach allows for causal inference regarding the protein's contribution to resistance mechanisms while controlling for potential confounding variables through appropriate experimental and statistical controls.

What methodological approaches are most suitable for analyzing protein-protein interactions involving UPF0102 protein Rv2898c/MT2966?

Multiple complementary methodologies should be employed to thoroughly characterize protein-protein interactions. In vitro approaches include pull-down assays, surface plasmon resonance (SPR), and isothermal titration calorimetry (ITC), which provide quantitative binding parameters. Yeast two-hybrid screening can identify novel interaction partners, though results should be validated using orthogonal methods. For in vivo confirmation, bimolecular fluorescence complementation (BiFC) or proximity ligation assays (PLA) provide spatial information about interactions within cellular contexts. Cross-linking mass spectrometry (XL-MS) can identify specific interaction interfaces, providing structural insights. Each method has specific strengths and limitations, necessitating a multi-method approach for comprehensive characterization. Experimental designs should include appropriate statistical analyses and follow the principles of quasi-experimental design when complete randomization is not possible .

How can gene expression studies of UPF0102 protein Rv2898c/MT2966 be integrated with phenotypic analyses of drug resistance?

Integration of gene expression data with phenotypic analyses requires careful experimental design and statistical methodology. Researchers should implement a comprehensive approach similar to that used for other M. tuberculosis proteins :

• Quantify Rv2898c expression levels using RT-qPCR with appropriate reference genes (e.g., polA) .

• Determine minimum inhibitory concentrations (MICs) for relevant antibiotics.

• Test MICs in the presence and absence of efflux pump inhibitors to evaluate the contribution of active efflux.

• Sequence relevant drug target genes to identify resistance-conferring mutations.

The following table illustrates a potential experimental design framework:

Statistical analysis should test for correlations between expression levels and MIC values, with careful attention to potential confounding variables. The integration of genotypic data (mutations) with expression and phenotypic data provides a comprehensive picture of resistance mechanisms .

What structural biology approaches would best elucidate the function of UPF0102 protein Rv2898c/MT2966?

A multi-technique structural biology approach is essential for functional elucidation. X-ray crystallography provides high-resolution structural information but requires successful crystallization. Nuclear magnetic resonance (NMR) spectroscopy is valuable for analyzing protein dynamics and ligand interactions in solution, particularly for identifying binding pockets. Cryo-electron microscopy (cryo-EM) can visualize larger protein complexes without crystallization. Computational approaches including homology modeling and molecular dynamics simulations can predict functional sites and potential binding partners.

Structure-function correlations should be tested experimentally through site-directed mutagenesis of predicted functional residues, followed by activity assays. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) can further identify regions undergoing conformational changes upon ligand binding. Integration of multiple structural methodologies provides complementary information that compensates for the limitations of any single approach, leading to more robust functional hypotheses.

How can researchers investigate the relationship between UPF0102 protein Rv2898c/MT2966 expression and clinical outcomes in tuberculosis infection?

Clinical correlation studies require careful design to establish meaningful associations. Researchers should:

• Collect clinical isolates from diverse patient populations with varied treatment outcomes.

• Quantify Rv2898c expression using RT-qPCR with appropriate normalization.

• Document detailed clinical metadata including treatment regimens, duration, and outcomes.

• Implement appropriate statistical methods including multivariate analysis to control for confounding variables.

The experimental design should follow time-series or multiple time-series approaches when tracking patient outcomes over the course of treatment . Quantifying additional biomarkers and related proteins can provide context for Rv2898c expression patterns. A regression-discontinuity analysis may be appropriate when examining treatment threshold effects . To strengthen causal inference, longitudinal sampling at multiple timepoints during treatment is preferable to single timepoint analysis. Researchers should incorporate quasi-experimental design elements when randomization is not ethically possible, carefully addressing threats to internal validity including history, maturation, testing effects, and selection bias .

What strategies can overcome solubility issues during recombinant UPF0102 protein Rv2898c/MT2966 expression?

Solubility challenges can be addressed through systematic optimization strategies. For E. coli expression systems, lowering induction temperature (16-18°C) and IPTG concentration (0.1-0.2 mM) significantly improves soluble protein yield. Fusion tags such as SUMO, MBP, or GST often enhance solubility more effectively than standard His-tags alone. Co-expression with chaperone proteins (GroEL/GroES) can facilitate proper folding. If inclusion bodies form despite optimization, protocols using mild detergents or chaotropic agents followed by stepwise dialysis can recover properly folded protein.

How can researchers address inconsistent results in UPF0102 protein Rv2898c/MT2966 functional assays?

Inconsistent functional assay results often stem from multiple sources of variation that must be systematically addressed. Protein quality heterogeneity between preparations is a common issue; implementing rigorous quality control metrics (e.g., thermal shift assays, activity benchmarking against reference preparations) helps ensure consistent starting material. Experimental procedures should be standardized with detailed protocols that specify critical parameters such as buffer composition, incubation times, and temperature control.

Statistical approaches for assay validation should include determination of intra- and inter-assay coefficients of variation, with acceptance criteria established before data collection. Implementing factorial experimental designs allows systematic evaluation of multiple variables simultaneously, efficiently identifying optimal conditions and potential interactions between factors . For particularly variable assays, implementing equivalent time-samples design or equivalent materials design can help control for temporal variations or material batch effects, respectively . Careful documentation of all experimental parameters in electronic laboratory notebooks facilitates troubleshooting when inconsistencies arise.

What methods are most effective for detecting and quantifying low-abundance UPF0102 protein Rv2898c/MT2966 in clinical samples?

Detecting low-abundance proteins in complex clinical samples requires specialized high-sensitivity methods. Targeted mass spectrometry approaches, particularly selected reaction monitoring (SRM) or parallel reaction monitoring (PRM), offer superior sensitivity and specificity compared to traditional proteomics workflows. Sample preparation should incorporate immunoaffinity enrichment steps using highly specific antibodies to concentrate the target protein before analysis.

For relative quantification across multiple samples, stable isotope labeling techniques such as SILAC or iTRAQ provide reliable comparative data. Absolute quantification can be achieved using synthetic isotope-labeled peptide standards corresponding to unique regions of Rv2898c. Digital PCR methodologies offer an alternative approach for quantifying mRNA expression with greater precision than standard qPCR, particularly at low abundance. When developing detection methods, validation should include determination of limits of detection and quantification using spiked samples that mimic the complexity of clinical specimens. Statistical approaches should address the challenges of left-censored data when measurements fall below detection limits.

How does the function of UPF0102 protein Rv2898c/MT2966 compare to other Mycobacterium tuberculosis efflux proteins?

Comparative functional analysis between Rv2898c and established M. tuberculosis efflux proteins requires consideration of structural, expression, and phenotypic characteristics. While Rv2898c remains less characterized than proteins like Rv3065 (mmr), Rv1258c (tap), Rv1410c (P55), Rv2459 (jefA), and Rv2942 (mmpL7) , emerging data suggests potential functional relationships.

Expression studies of known efflux pumps in MDR-TB isolates reveal variable patterns of overexpression, with Rv3065 showing the highest prevalence (22.7% of isolates), followed by Rv1410c (18.2%), Rv1258c (13.6%), Rv2459 (9%), and Rv2942 (9%) . These expression patterns correlate with phenotypic resistance in some but not all isolates, suggesting complex regulatory mechanisms. The expression profile of Rv2898c should be analyzed in a similar context to determine if it shows coordinated expression with these established efflux systems.

Structurally, efflux proteins in M. tuberculosis belong to different transporter families with distinct mechanisms. Comparative structural analysis can help position Rv2898c within these families and predict its potential substrates and transport mechanisms. Functional assays using fluorescent substrates and efflux inhibitors would provide direct evidence of Rv2898c's role in drug efflux compared to established transporters.

What is the evolutionary conservation of UPF0102 protein Rv2898c/MT2966 across mycobacterial species?

Evolutionary conservation analysis provides critical insights into functional importance and specialization. Comparative genomics approaches should examine the presence, sequence conservation, and genomic context of Rv2898c orthologs across:

• Pathogenic mycobacteria (M. tuberculosis complex, M. leprae, M. ulcerans)

• Non-pathogenic mycobacteria (M. smegmatis, M. vaccae)

• Related actinobacteria outside the Mycobacterium genus

Sequence conservation should be analyzed at both nucleotide and amino acid levels, with particular attention to functional domains and motifs. Synteny analysis examining the conservation of genomic neighborhood can reveal functional associations through gene clusters maintained throughout evolution. Selection pressure analysis using dN/dS ratios identifies regions under positive or purifying selection, highlighting functionally critical residues.

Phylogenetic reconstruction should employ multiple methodologies (maximum likelihood, Bayesian inference) to ensure robust evolutionary relationships. The resulting evolutionary context helps distinguish between Rv2898c functions that are core to mycobacterial physiology versus those potentially specialized for pathogenesis or environmental adaptation in specific lineages.

How do expression patterns of UPF0102 protein Rv2898c/MT2966 vary between drug-sensitive and drug-resistant Mycobacterium tuberculosis strains?

Differential expression analysis between drug-sensitive and resistant strains requires careful experimental design and appropriate statistical methods. Based on methodologies applied to other M. tuberculosis proteins , researchers should:

• Assemble a diverse collection of clinical isolates with well-characterized drug susceptibility profiles.

• Perform quantitative RT-PCR using validated primers and appropriate reference genes.

• Normalize expression data using the 2^-ΔΔCT method with H37Rv as reference strain .

• Establish clear thresholds for significant overexpression (>4-fold change is a common standard) .

The table below illustrates the expected experimental framework based on approaches used for similar proteins:

Statistical analysis should include non-parametric tests when data do not meet normality assumptions, with appropriate corrections for multiple comparisons. Correlation analyses between expression levels and MIC values for various antibiotics can reveal associations with specific resistance patterns . Multi-gene expression analysis examining Rv2898c alongside established resistance-associated genes provides context for interpretation and helps identify potential co-regulation patterns.

What gene knockout or knockdown approaches would best elucidate the essential nature of UPF0102 protein Rv2898c/MT2966?

Systematic gene manipulation approaches provide definitive evidence of essentiality and function. CRISPR interference (CRISPRi) systems adapted for mycobacteria offer tunable knockdown without complete deletion, making them ideal for studying potentially essential genes. Conditional knockdown systems using tetracycline-regulated promoters allow temporal control of expression, enabling the study of depletion effects in established cultures. For definitive essentiality testing, allelic exchange methods attempting to replace the native gene with a deletion construct will succeed only if the gene is non-essential.

Complementation studies are critical to confirm phenotypes are specifically due to Rv2898c manipulation rather than polar effects or off-target impacts. These should include both wild-type complementation and complementation with point-mutated versions targeting predicted functional residues. Essentiality testing should be conducted in multiple growth conditions (standard media, stress conditions, inside macrophages) as some genes are conditionally essential depending on environmental context. Transposon insertion sequencing (TnSeq) provides a genome-wide context for essentiality, allowing researchers to position Rv2898c within the broader network of essential and non-essential genes.

What high-throughput screening approaches could identify small molecule modulators of UPF0102 protein Rv2898c/MT2966 activity?

High-throughput screening for Rv2898c modulators requires development of robust, scalable assays reflecting the protein's function. If Rv2898c functions as an efflux pump, fluorescent substrate accumulation assays in whole cells or membrane vesicles provide a suitable screening platform. For screens based on direct binding, thermal shift assays (differential scanning fluorimetry) can detect ligand-induced stabilization across compound libraries. Surface plasmon resonance (SPR) or biolayer interferometry (BLI) enable label-free detection of binding interactions suitable for fragment-based screening approaches.

Primary screens should be followed by orthogonal validation assays to eliminate false positives. Structure-activity relationship studies on hit compounds help optimize potency and selectivity. Counter-screening against related proteins assesses selectivity, while mammalian cytotoxicity testing identifies potential safety concerns early in the discovery process. Medicinal chemistry optimization guided by structural insights can improve pharmacokinetic and pharmacodynamic properties of promising hits. Integration with phenotypic screens measuring effects on bacterial survival or drug susceptibility connects molecular activity to relevant biological outcomes.

How might the development of advanced research tools enhance our understanding of UPF0102 protein Rv2898c/MT2966 in host-pathogen interactions?

Advanced research tools are transforming our ability to study mycobacterial proteins in host contexts. Reporter fusion constructs (fluorescent or luminescent) enable real-time monitoring of Rv2898c expression and localization during infection. Single-cell RNA sequencing of infected host cells can reveal how Rv2898c expression varies across bacterial subpopulations and correlates with host response patterns. CRISPR-based genetic screens in host cells can identify host factors that interact with or are affected by Rv2898c activity.

Advanced microscopy techniques including super-resolution approaches allow visualization of Rv2898c localization within the complex mycobacterial cell envelope. Correlative light and electron microscopy (CLEM) can connect protein localization with ultrastructural features. Proximity labeling methods such as BioID or APEX2 can identify proximal proteins in the native context, revealing the protein's immediate interaction network.

The integration of these advanced tools with systems biology approaches including proteomics, metabolomics, and transcriptomics will position Rv2898c within the broader context of mycobacterial physiology and host-pathogen interaction networks. Computational models integrating these multi-omic datasets can generate testable hypotheses about emergent properties and network-level functions involving Rv2898c that would not be apparent from reductionist approaches alone.